Neurodegeneration in multiple sclerosis: novel treatment strategieswww.tandfonline.com › ... › Volume 12, Issue 9
www.tandfonline.com
· Neurodegeneration in multiple sclerosis: novel treatment strategies · Felix Luessi · Volker Siffrin · Frauke Zipp ...
Kinetics of IL-6 production defines T effector cell responsiveness to ...doaj.org › article
doaj.org
Bettina Trinschek,; Felix Luessi,; Jürgen Haas,; Brigitte Wildemann,; Frauke Zipp,; Heinz Wiendl,; Christian Becker,; Helmut Jonuleit. Affiliations.
Neurodegeneration in multiple sclerosis: novel treatment strategies....
www.scienceopen.com
Neurodegeneration in multiple sclerosis: novel treatment strategies. Authors: Frauke Zipp, Felix Luessi, Volker Siffrin. Publication date: ...
The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity...
www.scienceopen.com
Authors: Stephanie Hucke, Martin Herold, Marie Liebmann, Nicole Freise, Maren Lindner, Ann-Katrin Fleck, Stefanie Zenker, Stephanie Thiebes, Juncal Fernandez-Orth, Dorothea Buck, Felix Luessi, Sven G Meuth,, Frauke Zipp, Bernhard Hemmer,, Daniel Robert Engel, Johannes Roth, Tanja Kuhlmann, Heinz Wiendl,, ...
The Rare IL22RA2 Signal Peptide Coding Variant rs hal.science › hal
hal.science
... Felix Luessi (17) , Uwe K Zettl (13) , Frauke Zipp (17) , Iraide Alloza (1) , Manuel Comabella (7) , Christina M Lill (17) , Koen Vandenbroeck (1).
Alle Infos zum Namen "Felix Luessi"
Avances clínicos de la Esclerosis Múltiple
medicinaysaludpublica.com
Felix Luessi, Volker Siffrin & Frauke Zipp Review Neurodegeneration in multiple sclerosis: novel treatment strategies Pages
GFAPα IgG-associated encephalitis upon daclizumab treatment of MS |...
nn.neurology.org
Felix Luessi, Sinah Engel, Annette Spreer, Stefan Bittner, Frauke Zipp. First published July 13, 2018, DOI: https://doi.org NXI
Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B...
www.jimmunol.org
Rui Li, Ayman Rezk, Mathab Ghadiri, Felix Luessi, Frauke Zipp, Hulun Li, Paul S. Giacomini, Jack Antel and Amit Bar-Or. J Immunol December 14, 2016, ; DOI: https://doi.org jimmunol Rui Li. Neuroimmunology Unit, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, ...
Treatment response to dimethyl fumarate is characterized by ...journals.sagepub.com › doi › abs
journals.sagepub.com
... Timo Uphaus, Stefan Bittner, Sergiu Groppa, Björn Tackenberg, Amit Bar-Or, Frauke Zipp, and Felix Luessi+9-9View all authors and affiliations.
Abstract - :: JCN :: Journal of Clinical Neurologythejcn.com › search › jcn
thejcn.com
· Vinzenz Fleischer,a Anke Salmen,b Susanne Kollar,b Veronika Weyer,c Volker Siffrin,a Andrew Chan,b Frauke Zipp,a and Felix Luessi a.
Neurodegeneration in multiple sclerosis: novel treatment strategies -...
go.gale.com
includes Neurodegeneration in multiple sclerosis: novel treatment strategies by Felix Luessi, Volker Siffrin, and Frauke Zipp. Click to explore.
Identification of cortical lesions using DIR and FLAIR in early...
www.infona.pl
Identification of cortical lesions using DIR and FLAIR in early stages of multiple sclerosis. Pierre Kolber, Swantje Montag, Vinzenz Fleischer, Felix Luessi, Janine Wilting, Joachim Gawehn, Adriane Gröger, Frauke Zipp · Details · Contributors · Fields of science · Bibliography · Quotations · Similar · Collections ...
Gale Academic OneFile - Document - Neurodegeneration in multiple...
go.gale.com
Author(s): Felix Luessi 1 , Volker Siffrin 1 , Frauke Zipp [*] 2 Keywords : multiple sclerosis; neurodegeneration; neuronal injury; neuroprotection; treatment ...
PML risk stratification using anti-JCV antibody index and L-selectin...
read.qxmd.com
Nicholas Schwab, Tilman Schneider-Hohendorf, Béatrice Pignolet, Michela Spadaro, Dennis Görlich, Ingrid Meinl, Susanne Windhagen, Björn Tackenberg, Johanna Breuer, Ester Cantó, Tania Kümpfel, Reinhard Hohlfeld, Volker Siffrin, Felix Luessi, Anita Posevitz-Fejfár, Xavier Montalban, Sven G Meuth, Frauke Zipp, Ralf ...
Treatment response to dimethyl fumarate is characterized by...
www.growkudos.com
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS. Vinzenz Fleischer, Michaela Friedrich, Ayman Rezk, Ulrike Bühler, Esther Witsch, Timo Uphaus, Stefan Bittner, Sergiu Groppa, Björn Tackenberg, Amit Bar-Or, Frauke Zipp, Felix Luessi. Multiple Sclerosis Journal ...
sortiert nach Relevanz / Datum